Skip to main content

Advertisement

Log in

Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate

  • Short Communication
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Talniflumate was designed as a prodrug of niflumic acid, a potent analgesic and anti-inflammatory drug, which is widely prescribed for treating rheumatoid diseases. The prandial effect on talniflumate absorption remains unclear; therefore, this study investigated the effect of food on the systemic exposure to niflumic acid in healthy volunteers.

Methods

Volunteers received a single 740-mg dose of talniflumate 30 min after consuming a high-fat breakfast, a low-fat breakfast, or no food (fasting condition). Plasma concentrations of both talniflumate and niflumic acid were measured using validated high-performance liquid chromatography coupled to tandem mass spectrometry.

Results

The maximum concentration of niflumic acid was 224 ± 193 ng/ml at ∼2.7 h in the fasted condition compared with 886 ± 417 ng/ml (p < 0.05) at 1.8 h and 1,159 ± 508 ng/ml (p < 0.01) at 2.2 h with the low- and high-fat meals, respectively. The mean area under the curve from zero to infinity (AUCinf) values after the low- and high-fat meals were four- and fivefold, respectively, the value while fasting (p < 0.05).

Conclusions

It is strongly recommended that talniflumate be taken after a meal to increase systemic exposure to its active metabolite. Our results suggest a reduction in the daily dosage of talniflumate when taken with food.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Los M, Boned JE, Piccinali C (1981) New esters of substituted anilinonicotinic and phenylanthranilic acids. Farmaco 36:372–385

    CAS  Google Scholar 

  2. Vinci F, Fabbrocino S, Fiori M et al (2006) Determination of fourteen non-steroidal anti-inflammatory drugs in animal serum and plasma by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20:3412–3420

    Article  PubMed  CAS  Google Scholar 

  3. Lilja JJ, Backman JT, Neuvonen PJ (2007) Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam–probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther 81:833–839

    Article  PubMed  CAS  Google Scholar 

  4. Grenier J, Fradette C, Morelli G et al (2006) Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 79:255–262

    Article  PubMed  CAS  Google Scholar 

  5. Dresser GK, Km RB, Bailey DG (2005) Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Clin Pharmacol Ther 77:170–177

    Article  PubMed  CAS  Google Scholar 

  6. Thakker KM, Mangat S, Wagner W et al (1992) Effect of food and relative bioavailability following single doses of diclofenac 150 mg hydrogel bead (HGB) capsules in healthy humans. Biopharm Drug Dispos 13:327–335

    Article  PubMed  CAS  Google Scholar 

  7. Bannwarth B, Lapicque F, Netter P et al (1988) The effect of food on the systemic availability of ketoprofen. Eur J Clin Pharmacol 33:643–645

    Article  PubMed  CAS  Google Scholar 

  8. Dressman JB, Berardi RR, Elta GH et al (1992) Absorption of flurbiprofen in the fed and fasted states. Pharm Res 9:901–907

    Article  PubMed  CAS  Google Scholar 

  9. Ishizaki T, Nomura T, Abe T (1979) Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man. J Pharmacokinet Biopharm 7:369–381

    Article  PubMed  CAS  Google Scholar 

  10. Le Liboux A, Teule M, Frydman A et al (1994) Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen. Eur J Clin Pharmacol 47:361–366

    Article  PubMed  Google Scholar 

  11. Mroszczak EJ, Jung D, Yee J et al (1990) Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 10:33–39

    Google Scholar 

  12. Forbes JA, Sandberg RA, Bood Bjorklund L (1998) The effect of food on bromfenac, naproxen sodium, and acetaminophen in postoperative pain after orthopedic surgery. Pharmacotherapy 18:492–503

    PubMed  CAS  Google Scholar 

  13. Von Schrader HW, Buscher G, Dierdorf D et al (1983) Nabumetone-a novel anti-inflammatory drug: the influence of food, milk, antacids, and analgesics on bioavailability of single oral doses. Int J Clin Pharmacol Ther Toxicol 21:311–321

    Google Scholar 

  14. Olkkola KT, Neuvonen PJ (1984) Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol 18:663–669

    PubMed  CAS  Google Scholar 

  15. Yun HY, Lee EJ, Chung SY et al (2006) The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule. Clin Pharmacokinet 45:425–432

    Article  PubMed  CAS  Google Scholar 

  16. Neuvonen PJ, Kivisto KT (1988) Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. Eur J Clin Pharmacol 35:495–501

    Article  PubMed  CAS  Google Scholar 

  17. Leonard W, Judith A, Davud T (1993) The influence of food on the absorption and metabolism of drugs. Clin Nutr 77:815–829

    Google Scholar 

  18. Leibovitch ER, Deamer RL, Sanderson LA (2004) Careful drug selection and patient counseling can reduce the risk in older patients. Geriatrics 59:19–33

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wonku Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, W., Kim, K., Kim, EY. et al. Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate. Eur J Clin Pharmacol 64, 1027–1030 (2008). https://doi.org/10.1007/s00228-008-0524-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-008-0524-4

Keywords

Navigation